Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122,590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study.
Han Y, Liu H, Yang Y, Zhang J, Xu K, Fu G, Su X, Jiang T, Pang W, Chen J, Yuan Z, Li H, Wang H, Hong T, Liu H, Sun F, Allocco DJ, Zhang M, Dawkins KD. Han Y, et al. Among authors: li h. EuroIntervention. 2017 Nov 20;13(10):1210-1217. doi: 10.4244/EIJ-D-17-00271. EuroIntervention. 2017. PMID: 28741576 Free article. Clinical Trial.
Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.
Yuan F, Chen X, Song X, Wang D, Zhang Z, Li W, Li Z, Li H, Chen X, Huo Y, Wang L, Lu C, Lu Q, Xu B, Li W, Lyu S; HOPE Investigator. Yuan F, et al. Among authors: li z, li w, li h. Chin Med J (Engl). 2014;127(14):2561-6. Chin Med J (Engl). 2014. PMID: 25043067 Clinical Trial.
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: two-year results from a prospective patient-level pooled analysis of TARGET trials.
Gao Z, Zhang R, Xu B, Yang Y, Ma C, Li H, Chen S, Han Y, Yuan Z, Lansky AJ, Guan C, Leon MB, Gao R; TARGET Investigators. Gao Z, et al. Among authors: li h. Catheter Cardiovasc Interv. 2015 Mar;85 Suppl 1:734-43. doi: 10.1002/ccd.25861. Epub 2015 Feb 19. Catheter Cardiovasc Interv. 2015. PMID: 25678281
Efficacy and safety of a biodegradable polymer Cobalt-Chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials.
Wang G, Wang H, Xu B, Yang Y, Yang Z, Li H, Zhang Z, Wang H, Yang L, Han Y. Wang G, et al. Among authors: li h. Catheter Cardiovasc Interv. 2017 Mar;89(S1):512-519. doi: 10.1002/ccd.26887. Epub 2017 Jan 23. Catheter Cardiovasc Interv. 2017. PMID: 28112473
Efficacy and Safety of a Biodegradable Polymer Cobalt-Chromium Sirolimus-Eluting Stent (EXCEL2) in Treating De Novo Coronary Artery Disease: A Pooled Analysis of the CREDIT II and CREDIT III Trials. DOI: 10.1002/ccd.26887.
Wang G, Wang H, Xu B, Yang Y, Yang Z, Li H, Zhang Z, Wang H, Yang L, Han Y. Wang G, et al. Among authors: li h. Catheter Cardiovasc Interv. 2017 Oct 1;90(4):701. doi: 10.1002/ccd.27352. Catheter Cardiovasc Interv. 2017. PMID: 28990343 No abstract available.
Efficacy and safety of a second-generation biodegradable polymer sirolimus-eluting stent: One-year results of the CREDIT 2 trial.
Xu K, Han Y, Xu B, Yang Y, Wang G, Li H, Sun Y, Tao L, Wang H, Yuan Z, Liu H, Liu J, Jia Y, Ma G, Fu G, Li X, Li S, Wang S, Pu K; CREDIT 2 Investigators. Xu K, et al. Among authors: li s, li h, li x. Cardiovasc Ther. 2018 Jun;36(3):e12327. doi: 10.1111/1755-5922.12327. Epub 2018 Mar 25. Cardiovasc Ther. 2018. PMID: 29493880 Free article. Clinical Trial.
122,590 results
You have reached the last available page of results. Please see the User Guide for more information.